| Identification | Back Directory | [Name]
Alectinib M4 metabolite | [CAS]
1256585-04-2 | [Synonyms]
Alectinib M4
Alectinib M4 metabolite
Alectinib Impurity 1（Alectinib M4 metabolite）
9-Ethyl-8-(4-(2-hydroxyethylamino)piperidin-1-yl)-6,6-dimethyl-11-oxo-6,11-dihydro-5H-benzo[b]carbazole-3-carbonitrile
5H-Benzo[b]carbazole-3-carbonitrile, 9-ethyl-6,11-dihydro-8-[4-[(2-hydroxyethyl)amino]-1-piperidinyl]-6,6-dimethyl-11-oxo- | [Molecular Formula]
C28H32N4O2 | [MOL File]
1256585-04-2.mol | [Molecular Weight]
456.58 |
| Chemical Properties | Back Directory | [Melting point ]
>200°C | [Boiling point ]
731.1±60.0 °C(Predicted) | [density ]
1.29±0.1 g/cm3(Predicted) | [storage temp. ]
Refrigerator | [solubility ]
DMSO (Slightly), Methanol (Slightly, Heated) | [form ]
Solid | [pka]
13.70±0.40(Predicted) | [color ]
Off-White to Beige |
| Hazard Information | Back Directory | [Uses]
Alectinib M4 metabolite is the major active metabolite of Alectinib. Alectinib is an anaplastic lymphoma kinase (ALK) inhibitor and is used to treat non-?small-?cell lung cancer by blocking the activity of anaplastic lymphoma kinase (ALK). |
|
|